GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.710
-0.040 (-1.45%)
At close: Dec 5, 2025, 4:00 PM EST
2.711
+0.001 (0.04%)
After-hours: Dec 5, 2025, 7:34 PM EST
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $919.86 million as of December 5, 2025. Its market cap has decreased by -44.02% in one year.
Market Cap
919.86M
Enterprise Value
1.19B
1-Year Change
-44.02%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $919.86M, a decrease of -92.74%. That is a compound annual growth rate of -39.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 933.44M | -47.83% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |